Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus-Reference-Cited by-同舟云学术

Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus

Published:2024-05-14 Issue:1 Volume:35 Page:
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

González-López Tomás José¹,Bárez Abelardo²,Bernardo-Gutiérrez Ángel³,Bernat Silvia⁴,Fernández-Fuertes Fernando⁵,Guinea de Castro José María⁶,Jiménez-Bárcenas Reyes⁷,Jarque Isidro⁸

Affiliation:

1. Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain

2. Department of Hematology, Complejo Asistencial de Ávila, Ávila, Spain

3. Department of Hematology, Hospital Central de Asturias, Oviedo, Spain

4. Department of Hematology, Hospital Universitario de La Plana, Villarreal, Spain

5. Department of Hematology, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain

6. Department of Hematology, Hospital Universitario de Álava, Vitoria-Gasteiz, Spain

7. Department of Hematology, Hospital Serranía de Ronda, Málaga, Spain

8. Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Funder

Novartis, Amgen, Sobi, and Grifols

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2024.2336104

Reference42 articles.

1. Immune Thrombocytopenia

2. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

3. How I treat idiopathic thrombocytopenic purpura (ITP)

4. Immune thrombocytopenia ( ITP ) World Impact Survey ( I‐WISh ): Impact of ITP on health‐related quality of life

5. The ITP syndrome: pathogenic and clinical diversity